Clinical Pharmacy Process
Reference Book: Clinical Pharmacy and Therapeutics
Authors: D. G. Webb, J. G. Davies and D. McRobbie
Key Points
- Clinical pharmacy promotes the safe, effective, and economic use of medicines for individual patients.
- Shift from product-oriented roles to direct patient engagement.
- The three key elements of the care process: patient assessment, care plan determination, and outcome evaluation.
- Consultation skills are fundamental to delivering pharmaceutical care.
Overview
Clinical pharmacy is a practice where pharmacists shift focus from a solely product-oriented role toward more direct engagement with patients and their medicine-related problems. It embraces the philosophy of Pharmaceutical Care, which is a patient-centered system aimed at achieving specific positive outcomes.
Table 1.1: Drug Use Process (DUP) Indicators
| DUP Stage | Action |
|---|---|
| Need for a drug | Ensure appropriate indication and that all medical problems are addressed. |
| Select drug | Recommend the most appropriate drug based on therapeutic goals, patient variables, and cost. |
| Select regimen | Select the most appropriate regimen to achieve goals at the least cost without toxicity. |
| Provide drug | Facilitate accurate dispensing and timely delivery in ready-to-administer form. |
| Drug administration | Ensure appropriate devices and techniques are used. |
| Monitor therapy | Monitor for effectiveness or adverse effects to maintain, modify, or discontinue. |
| Counsel patient | Educate the patient/caregiver to ensure proper use. |
| Evaluate effectiveness | Review all previous steps to ensure therapeutic goals are achieved. |
Table 1.2: Core Definitions
| Term | Definition |
|---|---|
| Clinical Pharmacy | Functions that promote safe, effective, and economic use of medicines for individual patients. |
| Pharmaceutical Care | A co-operative, patient-centred system for achieving positive patient outcomes. |
| Medicines Management | How medicines are selected, procured, delivered, prescribed, administered, and reviewed to optimize outcomes. |
Medication-Related Problems (MRPs)
Categories of MRPs
- Untreated indication
- Treatment without indication
- Improper drug selection
- Too little drug / Too much drug
- Non-compliance
- Adverse drug reaction (ADR)
- Drug interaction
Preventable medication-related hospital admissions account for approximately 4.3% of cases in both the USA and UK. Many of these issues are linked to prescribing, monitoring, or adherence.
Pharmaceutical Consultation
Effective consultation involves establishing a therapeutic relationship. This is often more than just scientific expertise; it requires a partnership with the patient.
Common Mnemonics
WWHAM: Who is it for? What are the symptoms? How long? Action taken? Medicines taken?
AS METTHOD: Age, Self or someone else, Medicines, Exactly what symptom, Time/Duration, Taken action, History, Other symptoms, Doing anything to alleviate/worsen.
Table 1.4: Pharmaceutical Consultation Process
| Phase | Goal |
|---|---|
| Introduction | Building a therapeutic relationship. |
| Data collection | Identifying medication-related needs. |
| Actions & Solutions | Establishing an acceptable management plan. |
| Closure | Negotiating safety netting strategies. |
Clinical Pharmacy Functions
Step 1: Establishing Need
Identifying the patient's condition and expected therapy. Requires gathering details like age, gender, social history, and laboratory findings (Renal/Liver function).
Step 2: Selecting the Medicine
Checking for:
- Drug-Patient interactions: Allergies, age-related contraindications.
- Drug-Disease interactions: Medicine worsening a pre-existing condition.
- Drug-Drug interactions: Effects on metabolism (P450 system) or opposing actions.
Step 3: Administering the Medicine
Choosing the best route (Oral is preferred) and calculating accurate doses, especially for parenteral therapy.
Step 4: Providing the Medicine
Ensuring prescriptions are legal, legible, and that medicines are labeled accurately for the patient's specific needs.
Step 5: Monitoring Therapy
Scrutinizing medicines with narrow therapeutic indices (e.g., Digoxin, Warfarin, Phenytoin).
Case Study: Mr. JB
Profile: 67-year-old male, CHD, coronary artery stent, history of asthma (well-controlled).
| Recommendation | Rationale |
|---|---|
| Aspirin / Clopidogrel | Antiplatelet therapy for stent; used with caution in asthma. |
| Lansoprazole (PPI) | Decreases risk of GI bleeds from dual antiplatelets. |
| Simvastatin | Lower dose recommended due to diltiazem interaction. |
| Diltiazem | Used for rate control as Beta-blockers are contraindicated in asthma. |
PharmaQMS